BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, December 16, 2024
See today's BioWorld
Home
» Other news to note for Jan. 4, 2021
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full article
sign up for free
or
sign in
.
Other news to note for Jan. 4, 2021
Jan. 4, 2021
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Advaccine, Astrazeneca, Azurrx, Biocure, Bonus, Califia, Cheplapharm, Entheon, Epivax, First Wave, Generation, Heading, Hoth, Inovio, Lantern, Moderna, Novus, Oncorus, Symbasis, Taysha, Wize.
BioWorld
Briefs
Other news to note
Coronavirus